264 Correlation of virus-specific CD8+ T cells to clinical response following treatment with Pexa-Vec and Cemiplimab in patients with advanced renal cell carcinoma

Παρόμοια τεκμήρια

• VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial
  από: Tim F Greten, κ.ά.
  Έκδοση: (2024-01-01)
• 585 Ofranergene obadenovec (VB-111) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single-center, single-arm phase II trial
  από: David E Kleiner, κ.ά.
  Έκδοση: (2023-11-01)
• PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma
  από: Ghassan K. Abou-Alfa, κ.ά.
  Έκδοση: (2023-09-01)
• 264 Correlation of virus-specific CD8+ T cells to clinical response following treatment with Pexa-Vec and Cemiplimab in patients with advanced renal cell carcinoma
  από: Gavin Thurston, κ.ά.
  Έκδοση: (2020-11-01)
• Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma
  από: Cecilia Monge, κ.ά.
  Έκδοση: (2024-02-01)